Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jayanthi S Lea

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Cell|July 27, 2021
Ribosome ADP-ribosylation inhibits translation and maintains proteostasis in cancersSridevi Challa, Beman R Khulpateea, Tulip Nandu, et al.
Gynecologic Oncology|June 14, 2024
Predicting VTE and utility of thromboprophylaxis in metastatic and recurrent cervical cancerChristopher A Walker, Carson Edwards, Don McIntire, et al.
American Journal of Clinical Oncology|March 10, 2018
Emphasis on Systemic Therapy in Women With Pelvic Bone Metastasis at Time of Diagnosis of Cervical CancerDustin B Manders, Travis T Sims, Kevin V Albuquerque, et al.
Gynecologic Oncology|December 7, 2002
Endocervical curettage at conization to predict residual cervical adenocarcinoma in situJayanthi S Lea, Christine H Shin, Ellen E Sheets, et al.
American Journal of Clinical Oncology|May 22, 2018
The Significance of Para-Aortic Nodal Size and the Role of Adjuvant Systemic Chemotherapy in Cervical Cancer: An Institutional ExperienceDustin B Manders, Travis T Sims, April Bailey, et al.
The Journal of Investigative Dermatology|November 10, 2021
Human Papillomavirus‒Positive and ‒Negative Vulvar Squamous Cell Carcinoma Are Biologically but Not Clinically DistinctElysha Kolitz, Elena Lucas, Gregory A Hosler, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 17, 2015
A phase I-II evaluation of veliparib (NSC #737664), topotecan, and filgrastim or pegfilgrastim in the treatment of persistent or recurrent carcinoma of the uterine cervix: an NRG Oncology/Gynecologic Oncology Group studyCharles Kunos, Wei Deng, Dawn Dawson, et al.
BMC Genomics|April 1, 2017
Sparse feature selection for classification and prediction of metastasis in endometrial cancerMehmet Eren Ahsen, Todd P Boren, Nitin K Singh, et al.
The Journal of Clinical Investigation|September 29, 2015
LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitmentChristopher G Peña, Yuji Nakada, Hatice D Saatcioglu, et al.
American Journal of Clinical Oncology|February 23, 2017
Adjuvant External Radiation Impacts Outcome of Pelvis-limited Stage III Endometrial Carcinoma: A Multi-institutional StudyKevin Albuquerque, Michael Folkert, Jyoti Mayadev, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Cell|July 27, 2021
Ribosome ADP-ribosylation inhibits translation and maintains proteostasis in cancersSridevi Challa, Beman R Khulpateea, Tulip Nandu, et al.
Gynecologic Oncology|June 14, 2024
Predicting VTE and utility of thromboprophylaxis in metastatic and recurrent cervical cancerChristopher A Walker, Carson Edwards, Don McIntire, et al.
American Journal of Clinical Oncology|March 10, 2018
Emphasis on Systemic Therapy in Women With Pelvic Bone Metastasis at Time of Diagnosis of Cervical CancerDustin B Manders, Travis T Sims, Kevin V Albuquerque, et al.
Gynecologic Oncology|December 7, 2002
Endocervical curettage at conization to predict residual cervical adenocarcinoma in situJayanthi S Lea, Christine H Shin, Ellen E Sheets, et al.
American Journal of Clinical Oncology|May 22, 2018
The Significance of Para-Aortic Nodal Size and the Role of Adjuvant Systemic Chemotherapy in Cervical Cancer: An Institutional ExperienceDustin B Manders, Travis T Sims, April Bailey, et al.
The Journal of Investigative Dermatology|November 10, 2021
Human Papillomavirus‒Positive and ‒Negative Vulvar Squamous Cell Carcinoma Are Biologically but Not Clinically DistinctElysha Kolitz, Elena Lucas, Gregory A Hosler, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 17, 2015
A phase I-II evaluation of veliparib (NSC #737664), topotecan, and filgrastim or pegfilgrastim in the treatment of persistent or recurrent carcinoma of the uterine cervix: an NRG Oncology/Gynecologic Oncology Group studyCharles Kunos, Wei Deng, Dawn Dawson, et al.
BMC Genomics|April 1, 2017
Sparse feature selection for classification and prediction of metastasis in endometrial cancerMehmet Eren Ahsen, Todd P Boren, Nitin K Singh, et al.
The Journal of Clinical Investigation|September 29, 2015
LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitmentChristopher G Peña, Yuji Nakada, Hatice D Saatcioglu, et al.
American Journal of Clinical Oncology|February 23, 2017
Adjuvant External Radiation Impacts Outcome of Pelvis-limited Stage III Endometrial Carcinoma: A Multi-institutional StudyKevin Albuquerque, Michael Folkert, Jyoti Mayadev, et al.
Pageof 6